Article
Impact of MDM2 single nucleotide polymorphism on oral squamous cell carcinoma risk.
Cell biochemistry and biophysics - 1 Mar 2015
Xie Jian-Li, Yang Jing-Lei, Liu De-Sheng, Xie Yong-Gang, Ji Ping
Abstract excerpt
Mouse Double Minute 2 (MDM2) has emerged as a pivotal cellular antagonist of p53 by destructing the suppressive function of p53 against tumorigenesis. The MDM2 309 T > G polymorphism has been studied for its association with oral squamous cell carcinoma (OSCC) susceptibility, but the evidence was confusing and inconclusive. Here, we performed a meta-analysis to estimate the effects of the 309 T > G polymorphism...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
